Evidence map›Paper›PMID 39880313›Full record

ArticleThe Journal of allergy and clinical immunology2025

Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report-a GA

Timothy E Dribin, Antonella Muraro, Carlos A Camargo, Paul J Turner, Julie Wang, Graham Roberts, Aikaterini Anagnostou, Susanne Halken, Jay Liebermann, Margitta Worm and 3 more

Abstract readConsensus Statement
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. [How I treat anaphylaxis in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses.Immunology and allergy clinics of North America · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Timothy E DribinDivision of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: Timothy.Dribin@cchmc.org.
Antonella MuraroDepartment of Woman and Child Health, Food Allergy Centre, Padua University Hospital, Padua, Italy.
Carlos A CamargoDepartment of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Paul J TurnerNational Heart & Lung Institute, Imperial College London, London, United Kingdom.
Julie WangDivision of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
Graham RobertsUniversity of Southampton Faculty of Medicine, David Hide Asthma and Allergy Centre, Southampton, United Kingdom; St Mary's Hospital, Newport, United Kingdom; National Institute for Health Research Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Aikaterini AnagnostouDepartment of Pediatrics, Division of Immunology, Allergy and Retrovirology, Texas Children's Hospital, Houston, Tex; Division of Allergy, Immunology & Retrovirology, Baylor College of Medicine, Houston, Tex.
Susanne HalkenHans Christian Andersen Children's Hospital, Odense, Denmark; Denmark University of Southern Denmark, Odense, Denmark.
Jay LiebermannThe University of Tennessee Health Science Center, Memphis, Tenn.
Margitta WormDivision of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charite Univeritätsmedizin Berlin, Berlin, Germany.
Torsten ZuberbierFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany; Institute of Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Berlin, Germany.
Hugh A SampsonDivision of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
GA(2)LEN Anaphylaxis Study Team

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
KL2 Training ProgramKL2TR001426 · NCATS · UNIVERSITY OF CINCINNATI · PI ZELLER, MARGARET H · 2015 to 2024
$6.8M
Improving Anaphylaxis Outcomes Through Personalized Care StrategiesK23AI175525 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Timothy Erick Dribin · 2024 to 2026
$577k
NCATS NIH HHS KL2 TR001426NCATS NIH HHS UL1 TR001425NIAID NIH HHS K23 AI175525
6 · The paper itself

Abstract

backgroundThe 2006 National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network anaphylaxis criteria are widely used in clinical care and research. In 2020, the World Allergy Organization published modified criteria that have not been uniformly adopted. Different criteria contribute to inconsistent care and research outcomes.

objectiveWe sought to develop a consensus anaphylaxis definition, overview, and clinical support tool.

methodsA 12-member writing group developed draft outputs modified with input from a 46-member international expert panel, 31 medical stakeholder organizations, and 15 patient advocacy organizations. The expert panel participated in a modified Delphi process to seek consensus for the outputs using a ≥80% consensus threshold.

resultsThe first sentence of the definition reads, "Anaphylaxis is a serious allergic (hypersensitivity) reaction that can progress rapidly and may cause death." The definition also describes organ systems that may be involved and signs of life-threatening reactions. The overview includes details of anaphylaxis recognition and management. The clinical support tool incorporates new clinical criteria to help determine the likelihood that patients are having anaphylaxis, intramuscular epinephrine indications and dosing, and common findings from the anaphylaxis organ systems. In addition, 93.5% (43/46), 97.8% (45/46), and 93.5% (43/46) of experts agreed with the definition, overview, and clinical support tool, respectively.

conclusionThe anaphylaxis overview is a novel educational tool conveying key elements of anaphylaxis recognition and management. We propose that the definition and clinical support tool should replace previous definitions and clinical criteria. The clinical support tool should facilitate improved anaphylaxis recognition and management across different clinical settings and standardize research outcomes.

Indexed as

AnaphylaxisEpinephrineFood HypersensitivityHumansEpinephrineAdrenalineanaphylaxisclinical criteriadefinitionepinephrine

Identifiers

PMID39880313
PMCPMC12301991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.